[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

October 2017 | 350 pages | ID: GF49EF4E020EN
Data Bridge Market Research

US$ 4,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Spirometer Market is accounted to reach USD 1,041.3 million by 2024 from USD 553.9 million in 2016; it is growing at a CAGR of 8.3%.

The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.

The key market players for Global Spirometer Market are listed below:
  • BD,
  • Midmark Corp.
  • Welch allyn
  • SDI Diagnostics,
  • Geratherm Respiratory GMBH,
The market is further segmented into:
  • Type
  • Application
  • End User
  • Geography
The Global spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Global spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer. In 2017, table-top spirometer is expected to dominate the Global spirometer market with 39.3% market share and is expected to reach USD 404.4 million by 2024, growing a CAGR of 8.2% in the forecast period 2017 to 2024.

Based on technology, the Global spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Global spirometer market with 67.3% market share and is expected to reach USD 719.5 million by 2024, growing at a CAGR of 8.7% in the forecast period 2017 to 2024.

Based on disease, the Global spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Global spirometer market with 40.5% market share and is expected to reach USD 438.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on disposable components, the Global spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Global spirometer market with 74.0% market share and is expected to reach USD 781.6 million by 2024, growing with the highest CAGR of 8.6% in the forecast period 2017 to 2024.

Based on application, the Global spirometer market is segmented into diagnostics and therapeutic. In 2017, diagnostics is expected to dominate the Global spirometer market with 65.4% market share and is expected to reach USD 707.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on end-user, the Global spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Global spirometer market with 50.0% market share and is expected to reach USD 537.0 million by 2024, growing at a CAGR of 8.8% in the forecast period 2017 to 2024.

Based on distribution channel, the Global spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Global spirometer market with 64.4% market share and is expected to reach USD 684.0 million by 2024, growing at a CAGR of 8.6% in the forecast period 2017 to 2024.

Based on geography, the Global Spirometer market is segmented into 11 geographical regions, such as,
  • North America,
  • South America,
  • Europe,
  • APAC,
  • MEA
Covered in this report

The report covers the present scenario and the growth prospects of the Global Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.





INTRODUCTION

1.1. OVERVIEW OF THE GLOBAL SPIROMETER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2 MARKET SEGMENTATION

2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SPIROMETER MARKET SIZE
  2.2.1. MARKET CRACKDOWN APPROACH
  2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
  2.2.3. DATA TRIANGULATION
  2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
  2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
  2.2.6 PORTER’S FIVE FORCES MATRIX
  2.2.7 PEST ANALYSIS
  2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.3. GLOBAL SPIROMETER MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS

3 MARKET OVERVIEW

3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL SPIROMETER MARKET, BY PRODUCT TYPE

6.1. OVERVIEW
6.2. TABLE-TOP SPIROMETER
6.3. HAND-HELD SPIROMETER
6.4. DESKTOP(PC) SPIROMETER

7 GLOBAL SPIROMETER MARKET, BY TECHNOLOGY

7.1. OVERVIEW
7.2. VOLUME MEASUREMENT SPIROMETER(WET AND DRY)
7.3. FLOW MEASUREMENT SPIROMETER (PNEUMOTACHOGRAPH SYSTEM AND MASS FLOW METER)
7.4. PEAK FLOW METER (PFM)

8 GLOBAL SPIROMETER MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. DIAGNOSTIC
8.3. THERAPEUTIC

9 GLOBAL SPIROMETER MARKET, BY END USER

9.1. OVERVIEW
9.2. HOSPITALS
9.3. CLINIC
9.4. HOMECARE

10 GLOBAL SPIROMETER MARKET, BY APPLICATION

10.1. OVERVIEW
10.2. OVER THE COUNTER
10.3. DIRECT TENDER

11 GLOBAL SPIROMETER MARKET, BY GEOGRAPHY

11.1. COUNTRYWISE GLOBAL SPIROMETER MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
  11.1.1. NORTH AMERICA
    11.1.1.1. U.S.
    11.1.1.2. CANADA
    11.1.1.3. MEXICO
  11.1.2. EUROPE
    11.1.2.1. GERMANY
    11.1.2.2. FRANCE
    11.1.2.3. U.K.
    11.1.2.4 ITALY
    11.1.2.5 SPAIN
    11.1.2.6 RUSSIA
    11.1.2.7 TURKEY
    11.1.2.8 BELGIUM
    11.1.2.9NETHERLANDS
    11.1.2.10 SWITZERLAND
    11.1.2.11 REST OF EUROPE
  11.1.3 ASIA-PACIFIC (APAC)
    11.1.3.1 JAPAN
    11.1.3.2 CHINA
    11.1.3.3 SOUTH KOREA
    11.1.3.4 INDIA
    11.1.3.5 AUSTRALIA
    11.1.3.6 SINGAPORE
    11.1.3.7 THAILAND
    11.1.3.8 MALAYSIA
    11.1.3.9 INDONESIA
    11.1.3.10 PHILIPPINES
    11.1.3.11 REST OF APAC
  11.1.4 LATIN AMERICA
    11.1.4.1 BRAZIL
    11.1.4.2 REST OF LATIN AMERICA
  11.1.5 MIDDLE EAST AND AFRICA
    11.1.5.1 SOUTH AFRICA
    11.1.5.2 REST OF MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12 GLOBAL SPIROMETER MARKET: COMPETITIVE LANDSCAPE

12.1. GLOBAL SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.2. NORTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.4. APAC SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.5. MEA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.6. SOUTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.7. MERGERS & ACQUISITIONS
12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
12.9. EXPANSIONS
12.10. REGULATORY CHANGES
12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

13.1 WELCH ALLYN
  13.1.1 COMPANY OVERVIEW
  13.1.2 FINANCIAL ANALYSIS
  13.1.3 PRODUCT MATRIX
  13.1.4 RECENT DEVELOPMENTS
  13.1.5 DATABRIDGE ANALYSIS
13.2 MIDMARK CORP.
  13.2.1 COMPANY OVERVIEW
  13.2.2 FINANCIAL ANALYSIS
  13.2.3 PRODUCT MATRIX
  13.2.4 RECENT DEVELOPMENTS
  13.2.5 DATABRIDGE ANALYSIS
13.3 FUTUREMED
  13.3.1 COMPANY OVERVIEW
  13.3.2 FINANCIAL ANALYSIS
  13.3.3 PRODUCT MATRIX
  13.3.4 RECENT DEVELOPMENTS
  13.3.5 DATABRIDGE ANALYSIS
13.4 COSMED
  13.4.1 COMPANY OVERVIEW
  13.4.2 FINANCIAL ANALYSIS
  13.4.4 PRODUCT MATRIX
  13.4.4 RECENT DEVELOPMENTS
  13.4.5 DATABRIDGE ANALYSIS
13.5 MGC DIAGNOSTICS CORPORATION
  13.5.1 COMPANY OVERVIEW
  13.5.2 FINANCIAL ANALYSIS
  13.5.3 PRODUCT MATRIX
  13.5.4 RECENT DEVELOPMENTS
  13.5.5 DATABRIDGE ANALYSIS
13.6 NIHON KOHDEN CORPORATION
  13.6.1 COMPANY OVERVIEW
  13.6.2 FINANCIAL ANALYSIS
  13.6.3 PRODUCT MATRIX
  13.6.4 RECENT DEVELOPMENTS
  13.6.5 DATABRIDGE ANALYSIS
13.7 CAREFUSION CORPORATION
  13.7.1 COMPANY OVERVIEW
  13.7.2 FINANCIAL ANALYSIS
  13.7.3 PRODUCT MATRIX
  13.7.4 RECENT DEVELOPMENTS
  13.7.5 DATABRIDGE ANALYSIS
13.8 MEDICAL INTERNATIONAL RESEARCH
  13.8.1 COMPANY OVERVIEW
  13.8.2 FINANCIAL ANALYSIS
  13.8.3 PRODUCT MATRIX
  13.8.4 RECENT DEVELOPMENTS
  13.8.5 DATABRIDGE ANALYSIS
13.9 VITALOGRAPH
  13.9.1 COMPANY OVERVIEW
  13.9.2 FINANCIAL ANALYSIS
  13.9.3 PRODUCT MATRIX
  13.9.4 RECENT DEVELOPMENTS
  13.9.5 DATABRIDGE ANALYSIS
13.10 NDD MEDICAL TECHNOLOGIES, INC.
  13.10.1 COMPANY OVERVIEW
  13.10.2 FINANCIAL ANALYSIS
  13.10.3 PRODUCT MATRIX
  13.10.4 RECENT DEVELOPMENTS
  13.10.5 DATABRIDGE ANALYSIS
13.11 SCHILLER AG
  13.11.1 COMPANY OVERVIEW
  13.11.2 FINANCIAL ANALYSIS
  13.11.3 PRODUCT MATRIX
  13.11.4 RECENT DEVELOPMENTS
  13.11.5 DATABRIDGE ANALYSIS
13.12 JONES MEDICAL INSTRUMENT COMPANY
  13.12.1 COMPANY OVERVIEW
  13.12.2 FINANCIAL ANALYSIS
  13.12.3 PRODUCT MATRIX
  13.12.4 RECENT DEVELOPMENTS
  13.12.5 DATABRIDGE ANALYSIS

14 APPENDIX

15 ABOUT DATA BRIDGE MARKET RESEARCH


More Publications